Study on TIL for the Treatment of Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Treatment Side Effects|Advanced Breast Cancer|Effects of Immunotherapy
Interventions: BIOLOGICAL: Tumor Infiltrating Lymphocytes (TIL)
Sponsor: Shanghai Juncell Therapeutics
Collaborators: Shanghai 10th People's Hospital